Alfresa : Other New Businesses, Overseas Business

Business Strategy

Other New Businesses, Overseas Business

Treatment-Adjacent Businesses (Beauty, Animal-Related)

Shigeki Ohashi

Director, Vice President & Executive Officer

General Manager of Group Ethical Wholesaling Business,

International Business

Alfresa Holdings Corporation

Other New Businesses

The beauty and animal-related fields are expected to continue expanding as more people seek lifestyles of greater abundance. We will move closer to our aim of becoming a Healthcare Consortium by leveraging the distribution capabilities and expertise cultivated in the Ethical

Dispensing Centers

If regulations concerning dispensing operations are relaxed, it will become possible to restructure the pharmaceuticals supply chain and make it more efficient by centralizing the dispensing function. Deploying highly automated equipment at dispensing centers could reduce problems caused by

Pharmaceuticals Wholesaling Business and expanding into the beauty and animal-related sectors, which are closely related to healthcare. By doing so, we aspire to achieve the Group's founding principle of "creating and delivering a fresh life for all."

human error and allow pharmacists to focus on the interpersonal aspects of their roles, boosting productivity. We will seek to help our customer pharmacies streamline their operations by sharing the expertise we have cultivated as a pharmaceuticals wholesaler and engaging in collaborations.

Healthtech and Data-Driven Businesses

In health technology (healthtech) and data-driven businesses,	customer satisfaction by streamlining operations and achiev-
we strive to create new value and address challenges in the	ing a high level of standardization. Meanwhile, we plan to
field of health and medicine by leveraging various digital	venture into new areas of business related to health and
tools. Through DX promotion and other initiatives, we aim to	medicine by converting the information gleaned by connect-

Overseas Business

Business Overview

advance our activities that connect healthcare professionals	ing people into useful data that we can monetize by providing
to a new stage through digitalization. We strive to improve	it to customers.

The Alfresa Group currently operates overseas in two coun- tries: China and Vietnam. In China, we established REMEJE PHARMACEUTICALS (CHINA) CO., LTD., 2005, as a distributor of pharmaceuticals and healthcare-related products. REMEJE

selling surgical sutures, the Chinese company aims to build a business in importing and selling diagnostic reagents and medical devices. In Vietnam, we established Alfresa Codupha Healthcare Vietnam Co., Ltd., in 2013 with a local partner,

Take advantage of digital tools to bring connectivity to the next stage

Hospitals

Introduce digital technology that will connect treatment-related

stakeholders

PHARMACEUTICALS imports OTC drugs, medical devices, cosmetics, health foods, and other items from Japan and wholesales them to hospitals and pharmacies in China. Also, Alfresa Pharma Corporation established QINGDAO NESCO MEDICAL CO., LTD. In addition to producing, exporting, and

Codupha, a wholesaler of medical products. By leveraging the Alfresa Group's abundant capacity to supply healthcare- related products and Codupha's nationwide network in Vietnam, we aim to contribute to that country's medical and health fields by providing advanced, high-quality services.

Key hospitals	MS-MR
Specialized doctors

Progress on Business Policies in the 22-24Mid-term Management Plan

Visiting nurses
	Support workstyle
	reforms of medical care	Patients and
*	professionals
	members of the
		local community

Build a community of

local doctors

Dispensing pharmacies

and drugstores

Clinic-based

doctors

Note: Yakubato is a service provided by Yakubato Co., Ltd.

Nursing care facilities

Utilize databases and

other methods to connect

multiple professions

Clinics

The 22-24Mid-term Management Plan calls for us to expand our operations in the Asian market by deepening and expanding our existing businesses, as well as by actively pursuing business development and new ventures.

One major area of progress toward deepening and expanding our existing businesses lies in ongoing efforts to expand the product lineup at REMEJE PHARMACEUTICALS. Meanwhile, as the market grows, the number of Japanese-affiliated medical

facilities and health examination centers is increasing in Vietnam. Alfresa Codupha Healthcare Vietnam aims to boost its revenue by providing services that target these customers. We are also preparing to enter the pharmaceuticals business in Vietnam. In terms of business development and new initia- tives, we are actively exploring collaborations with new market entrants and overseas companies, as well as considering and verifying new business models.

38

Alfresa Group Integrated Report 2023

Alfresa Group Integrated Report 2023

39